Improved prediction of haematological toxicity during [177Lu]Lu-DOTA-TATE therapy by optimising serial SPECT-CT red marrow dosimetry

被引:0
|
作者
Tipping, J. [1 ]
Page, E. [1 ]
Calvert, N. [1 ]
Hamilton, D. [1 ]
Cullen, D. [2 ]
Price, E. [2 ]
Pells, S. [2 ]
Needham, G. [2 ]
Manoharan, P. [1 ]
机构
[1] Christie NHS Fdn Trust, Manchester, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-474
引用
收藏
页码:S239 / S239
页数:1
相关论文
共 50 条
  • [41] [177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center
    Prado-Wohlwend, Stefan
    del Olmo-Garcia, Maria Isabel
    Bello-Arques, Pilar
    Merino-Torres, Juan Francisco
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [42] Uncertainty propagation for SPECT/CT-based renal dosimetry in 177Lu peptide receptor radionuclide therapy
    Gustafsson, Johan
    Brolin, Gustav
    Cox, Maurice
    Ljungberg, Michael
    Johansson, Lena
    Gleisner, Katarina Sjogreen
    PHYSICS IN MEDICINE AND BIOLOGY, 2015, 60 (21): : 8329 - 8346
  • [43] [177Lu]Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The NETTER-2 Study
    Singh, Simron
    Pavel, Marianne
    Kunz, Pamela L.
    de Herder, Wouter
    Herrmann, Ken
    D'Amelio, Anthony M., Jr.
    Santoro, Paola
    Folitar, Ilya
    Ferone, Diego
    PANCREAS, 2022, 51 (03) : E58 - E58
  • [44] Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
    Gadens Zamboni, Camila
    Dundar, Ayca
    Jain, Sanchay
    Kruzer, Marc
    Loeffler, Bradley T.
    Graves, Stephen A.
    Pollard, Janet H.
    Mott, Sarah L.
    Dillon, Joseph S.
    Graham, Michael M.
    Menda, Yusuf
    Shariftabrizi, Ahmad
    EJNMMI REPORTS, 2024, 8 (01)
  • [45] A phase II trial to evaluate the safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs), pheochromocytomas and paragangliomas (PPGLs)
    Gaze, M. N.
    O'Dorisio, M. S.
    Sabado, C.
    Brouri, F.
    Folitar, I.
    ANNALS OF ONCOLOGY, 2021, 32 : S920 - S920
  • [46] [177LU]LU-DOTA-TATE AS FIRST-LINE THERAPY FOR PATIENTS WITH GRADE 2 AND 3 ADVANCED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOURS (GEP-NETS): THE NETTER-2 STUDY
    Myrehaug, Sten
    Singh, Simron
    Pavel, Marianne
    Kunz, Pamela
    de Herder, Wouter
    Herrmann, Ken
    D'Amelio, Anthony, Jr.
    Santoro, Paola
    Folitar, Ilya
    Ferone, Diego
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S40 - S41
  • [47] Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
    Mansouri, Zahra
    Salimi, Yazdan
    Akhavanallaf, Azadeh
    Shiri, Isaac
    Teixeira, Eliluane Pirazzo Andrade
    Hou, Xinchi
    Beauregard, Jean-Mathieu
    Rahmim, Arman
    Zaidi, Habib
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (06) : 1516 - 1529
  • [48] Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy
    Zahra Mansouri
    Yazdan Salimi
    Azadeh Akhavanallaf
    Isaac Shiri
    Eliluane Pirazzo Andrade Teixeira
    Xinchi Hou
    Jean-Mathieu Beauregard
    Arman Rahmim
    Habib Zaidi
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1516 - 1529
  • [49] A Phase II Trial to Evaluate the Safety and Dosimetry of [177Lu] Lu-DOTA-TATE in Adolescent Patients With Somatostatin Receptor (SSTR)-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), Pheochromocytomas and Paragangliomas (PPGLs)
    O'Dorisio, M. Sue
    Gaze, Mark
    Sabado, Constantino
    Brouri, Fazia
    Folitar, Ilya
    PANCREAS, 2022, 51 (03) : E59 - E59
  • [50] Models using comprehensive, lesion-level, longitudinal [68Ga]Ga-DOTA-TATE PET-derived features lead to superior outcome prediction in neuroendocrine tumor patients treated with [177Lu]Lu-DOTA-TATE
    Santoro-Fernandes, Victor
    Schott, Brayden
    Deatsch, Ali
    Keigley, Quinton
    Francken, Thomas
    Iyer, Renuka
    Fountzilas, Christos
    Perlman, Scott
    Jeraj, Robert
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (11) : 3428 - 3439